Zwanenburg, Laurens
Borloo, Jimmy
Decorte, Bregt
Bunte, Myrna J. M.
Mokhtari, Sanaz
Serna, Sonia
Reichardt, Niels-C.
Seys, Leen J. M.
van Diepen, Angela
Schots, Arjen
Wilbers, Ruud H. P.
Hokke, Cornelis H.
Claerebout, Edwin
Geldhof, Peter
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek
Horizon 2020 Framework Programme
International Coordination of Research on Infectious Animal Diseases 2021
Ministry of Science and Education (MINECO),Spain (Grant Nos. CTQ 2017-90039-R and RTC-2017-6126-1, Grant Nos. CTQ 2017-90039-R and RTC-2017-6126-1)
Agencia Estatal de Investigación (AEI Grant No PID2020-117552RB-I00, AEI Grant No PID2020-117552RB-I00)
Maria de Maeztu Units of Excellence Program (Grant No. MDM-2017-0720, Grant No. MDM-2017-0720)
Basque Government (Elkartek grant bmg21, Elkartek grant bmg21)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (TTW Veni Grant 16740)
Article History
Received: 13 July 2023
Accepted: 14 November 2023
First Online: 22 November 2023
Competing interests
: L.Z.’s work was partially funded by Zoetis Inc., specifically related to the bovine immunisation-infection studies to evaluate the protective capacity of the N. benthamiana recombinants. This funding was solely required to cover the cost for animal purchase, housing and technical assays related to these studies. Furthermore, Ghent University possesses the intellectual property rights of the native and N. benthamiana recombinant vaccine. J.B., B.D., M.B., S.M., S.S., N.C.R., L.S., A.vD., A.S., R.H.P.W., C.H.H., E.C. and P.G. declare no potential conflict of interest.